UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000025760
Receipt No. R000029636
Scientific Title Randomized controlled trial on efficacy of metal stents vs. inside plastic stents for unresectable malignant obstruction of the perihilar bile duct
Date of disclosure of the study information 2017/02/24
Last modified on 2020/01/23 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Randomized controlled trial on efficacy of metal stents vs. inside plastic stents
for unresectable malignant obstruction of the perihilar bile duct
Acronym MiPS study
Scientific Title Randomized controlled trial on efficacy of metal stents vs. inside plastic stents
for unresectable malignant obstruction of the perihilar bile duct
Scientific Title:Acronym MiPS study
Region
Japan

Condition
Condition Unresectable malignant perihilar biliary obstruction
Classification by specialty
Hepato-biliary-pancreatic medicine
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate the efficacy of placement of inside plastic stents (PSs)
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Patency period of inside PSs
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification NO
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Device,equipment
Interventions/Control_1 Deployment of inside PSs
Interventions/Control_2 Deployment of metal stents (MSs)
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria a. those who have been diagnosed as malignant perihilar biliary obstruction with Bismuth level 2 or more.
b. Clinically non resectable
c. Total biliarubin =/> 2.0 mg/dL
d. No history of previous biliary stent placement
e. Expected prognosis > 3 months
f. Obtaining written informed concent
Key exclusion criteria a. No tolerance of endoscopic procedures
b. ASA class 4 or more
c. Reconstructed upper GI tract
d. State after papillectomy, surgical biliojejunostomy
e. Planned for surgical resection, radiotherapy, PDT, or HIFU
f. Planned for scheduled replacement of PSs
g. State after placement of irremoval biliary stents
h. Tumors extending to lower bile duct
i. Tumors which have already invaded to broad area and which was considered to be difficult to treat with biliary drainage
j. Tumors with papillary growth
k. Active infectious inflammation
l. PSC, IgG4-SC and PBC
m. LC stage Child-Pugh C
n. Hemolyzing disease
o. Allergic for contrast
Target sample size 130

Research contact person
Name of lead principal investigator
1st name Yoshihide
Middle name
Last name Kanno
Organization Sendai City Medical Center
Division name Department of Gastroenterology
Zip code 9810913
Address 5-22-1, Tsurugaya, Miyagino-ku, Sendai, Japan
TEL 022-252-1111
Email yoshi-hk@openhp.or.jp

Public contact
Name of contact person
1st name Yoshihide
Middle name
Last name Kanno
Organization Sendai City Medical Center
Division name Department of Gastroenterology
Zip code 981-0913
Address 5-22-1, Tsurugaya, Miyagino-ku, Sendai, Japan
TEL 022-252-1111
Homepage URL
Email yoshi-hk@openhp.or.jp

Sponsor
Institute Sendai City Medical Center
Institute
Department

Funding Source
Organization Sendai City Medical Center
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Institutional Review Board of Sendai City Medical Center
Address Tsurugaya 5-22-1, Miyagino-ku, Sendai, Miyagi, Japan
Tel 0222521111
Email yoshihk44@yahoo.co.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 02 Month 24 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2017 Year 01 Month 20 Day
Date of IRB
2017 Year 03 Month 01 Day
Anticipated trial start date
2017 Year 03 Month 01 Day
Last follow-up date
2020 Year 12 Month 31 Day
Date of closure to data entry
2021 Year 06 Month 30 Day
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2017 Year 01 Month 20 Day
Last modified on
2020 Year 01 Month 23 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000029636